BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26551569)

  • 21. Late-Onset Lymphopenia and ITP in a Patient with Hyper IgM Syndrome Due to a Homozygous Variant in AICDA.
    Adatia A; Ritchie B
    J Clin Immunol; 2023 Oct; 43(7):1540-1542. PubMed ID: 37402930
    [No Abstract]   [Full Text] [Related]  

  • 22. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
    Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
    J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.
    Tsujita Y; Imai K; Honma K; Kamae C; Horiuchi T; Nonoyama S
    J Clin Immunol; 2018 Jan; 38(1):144-148. PubMed ID: 29255996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 hyper-IgM syndrome with a rare variant of AICDA gene mutation in a young woman.
    Prakash PR; Gupta G; Aggarwal M; Baitha U
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36931691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyper IgM Syndrome with low IgM and thrombocytosis: an unusual case of immunodeficiency.
    Yousef E; Arshad Alvi M
    Eur Ann Allergy Clin Immunol; 2016 Sep; 48(5):194-6. PubMed ID: 27608476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic hypermutation defects in two adult hyper immunoglobulin M patients.
    Yilmaz H; Fırtına S; Sarıtaş M; Sayitoğlu M; Ar MC
    Immunol Res; 2022 Dec; 70(6):811-816. PubMed ID: 35879489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyper-IgM syndrome--a case report and a clinical perspective.
    Silva R; Da Costa JT
    Eur Ann Allergy Clin Immunol; 2010 Oct; 42(5):194-6. PubMed ID: 21192628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
    Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
    Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.
    Yazdani R; Fekrvand S; Shahkarami S; Azizi G; Moazzami B; Abolhassani H; Aghamohammadi A
    Clin Immunol; 2019 Jan; 198():19-30. PubMed ID: 30439505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
    Revy P; Muto T; Levy Y; Geissmann F; Plebani A; Sanal O; Catalan N; Forveille M; Dufourcq-Labelouse R; Gennery A; Tezcan I; Ersoy F; Kayserili H; Ugazio AG; Brousse N; Muramatsu M; Notarangelo LD; Kinoshita K; Honjo T; Fischer A; Durandy A
    Cell; 2000 Sep; 102(5):565-75. PubMed ID: 11007475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression.
    Karaca NE; Forveille M; Aksu G; Durandy A; Kutukculer N
    Scand J Immunol; 2012 Jul; 76(1):21-5. PubMed ID: 22443339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biased immunoglobulin G (IgG) subclass production in a case of hyper-IgM syndrome.
    McLean GR; Miller KK; Schrader JW; Junker AK
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1192-3. PubMed ID: 15539528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyper IgM syndrome presenting as chronic suppurative lung disease.
    Montella S; Maglione M; Giardino G; Di Giorgio A; Palamaro L; Mirra V; Ursini MV; Salerno M; Pignata C; Caffarelli C; Santamaria F
    Ital J Pediatr; 2012 Sep; 38():45. PubMed ID: 22992442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland.
    Trotta L; Hautala T; Hämäläinen S; Syrjänen J; Viskari H; Almusa H; Lepisto M; Kaustio M; Porkka K; Palotie A; Seppänen M; Saarela J
    Eur J Hum Genet; 2016 Oct; 24(10):1473-8. PubMed ID: 27142677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hyper IgM syndrome--an evolving story.
    Etzioni A; Ochs HD
    Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The hyper-IgM syndrome: 13 observations].
    Bejaoui M; Mellouli F; Chouanine R; Dellagi K; Barbouche MR
    Presse Med; 2003 Mar; 32(12):544-9. PubMed ID: 12714921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.
    Tafakori Delbari M; Cheraghi T; Yazdani R; Fekrvand S; Delavari S; Azizi G; Chavoshzadeh Z; Mahdaviani SA; Ahanchian H; Khoshkhui M; Behmanesh F; Aleyasin S; Esmaeilzadeh H; Jabbari-Azad F; Fallahpour M; Zamani M; Madani SP; Moazzami B; Habibi S; Rezaei A; Lotfalikhani A; Movahed M; Shariat M; Kalantari A; Babaei D; Darabi M; Parvaneh N; Rezaei N; Abolhassani H; Aghamohammadi A
    Int Arch Allergy Immunol; 2019; 180(1):52-63. PubMed ID: 31117086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency.
    Kashef S; Ghaedian MM; Rezaei N; Karamizadeh Z; Aghamohammadi A; Durandy A; Pan-Hammarstrom Q; Hammarstrom L
    J Investig Allergol Clin Immunol; 2009; 19(3):233-6. PubMed ID: 19610268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.